Harnessing defective viruses to fight infections
- PMID: 35590140
- DOI: 10.1016/j.medj.2021.12.006
Harnessing defective viruses to fight infections
Abstract
One of the most pressing challenges in medicine is to develop fast and effective strategies to combat infections. Xiao et al.1 report proof-of-concept experiments for the use of defective viral genomes as broad-spectrum antivirals by harnessing their ability to stimulate the innate immune response.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests C.B.L. has a related patent: Methods and Compositions for Stimulating Immune Response Using Potent Immunostimulatory RNA Motifs, patent number 10,624,964, granted on April 21, 2020. The priority date for the patent is May 1, 2015.
Comment on
-
A defective viral genome strategy elicits broad protective immunity against respiratory viruses.Cell. 2021 Dec 9;184(25):6037-6051.e14. doi: 10.1016/j.cell.2021.11.023. Epub 2021 Nov 18. Cell. 2021. PMID: 34852237 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
